Global Market Outlook for Neurotrophic Keratitis (2018-2027), Featuring COVID-19 Impact -

DUBLIN--()--The "Neurotrophic Keratitis - Global Market Outlook (2018-2027)" report has been added to's offering.

The Global Neurotrophic Keratitis market accounted for $60.56 million in 2018. A rise in reported cases and a surge in investments in research, clinical studies and product approvals are the major factors propelling market growth. However, on the flipside the high cost of treatment is hampering market growth.

Based on treatment, the drugs segment is set to experience lucrative growth during the forecast period as artificial tears are prescribed for all stages due to their ability to provide wetness and lubrication to the corneal surface and ensure cleanliness. By geography, North America is set to experience strong during the forecast period owing to a rise in product approvals, a well-established health care infrastructure, an increase in technological advancements, a rise in the number of well-equipped laboratories and the presence of key players.

Some of the key players profiled in the report include Walgreens, ReGenTree, LLC, Novartis AG, Dompefarmaceutici S.p.A., CooperVision, Bayer AG, Bausch & Lomb Incorporated, Allergan, Plc., Abbott Laboratories, Inc. and Johnson & Johnson.

Treatments Covered:

  • Drugs
  • Surgical Intervention

Stages Covered:

  • Stage I
  • Stage II
  • Stage III

Applications Covered:

  • Clinic
  • Hospital

What the report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.5 Research Sources

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Application Analysis

3.7 Emerging Markets

3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Neurotrophic Keratitis Market, By Treatment

5.1 Introduction

5.2 Drugs

5.2.1 Topical Antibiotics

5.2.2 RGN-259

5.2.3 Recombinant Human Nerve Growth Factors Eye Drop

5.2.4 Oral Antibiotics

5.2.5 Bandage Contact Lens

5.2.6 Artificial Tears

5.3 Surgical Intervention

5.3.1 Tarsorrhaphy

5.3.2 Amniotic Membrane Transplantation

6 Global Neurotrophic Keratitis Market, By Stage

6.1 Introduction

6.2 Stage I

6.3 Stage II

6.4 Stage III

7 Global Neurotrophic Keratitis Market, By Application

7.1 Introduction

7.2 Clinic

7.3 Hospital

8 Global Neurotrophic Keratitis Market, By Geography

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures

9.2 Acquisitions & Mergers

9.3 New Product Launch

9.4 Expansions

9.5 Other Key Strategies

10 Company Profiling

10.1 Walgreens

10.2 ReGenTree LLC

10.3 Novartis AG

10.4 Dompe farmaceutici S.p.A.

10.5 CooperVision

10.6 Bayer AG

10.7 Bausch & Lomb Incorporated

10.8 Allergan Plc

10.9 Abbott Laboratories Inc

10.10 Johnson & Johnson

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900